Tamsulosin Hydrochloride Capsule
Product Images NDC 63672-0021

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Tamsulosin Hydrochloride (NDC 63672-0021). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Synthon Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Tamsulosin 01)

Chemical structure of tamsulosin hydrochloride, showing the arrangement of atoms and functional groups characteristic of this active ingredient.*

FDA Label Image

Figure 1 (Tamsulosin 02)

A pharmacokinetic plot showing plasma concentration (mg/mL) of tamsulosin hydrochloride capsules over time (hours) after oral administration. The graph compares plasma levels under fasted and fed conditions, illustrating concentration changes up to 36 hours.*

FDA Label Image

Figure 2a (Tamsulosin 03)

A line graph showing the mean change over duration of treatment in weeks for three groups: Tamsulosin hydrochloride 0.8 mg, 0.4 mg, and placebo. The y-axis represents mean change, and the x-axis represents treatment duration from baseline to 13 weeks. The graph includes sample sizes at each time point and indicates statistically significant differences between treatment groups and placebo at 13 weeks.*

FDA Label Image

Figure 2b (Tamsulosin 04)

A line graph showing the mean change in a measured variable over a treatment duration in weeks. The x-axis represents treatment duration from 0 to 13 weeks plus a last observation carried forward (LOCF) point. The y-axis shows mean change ranging from 0 to -11. Three groups are plotted: placebo (square markers), 0.4 mg dose (triangle markers), and 0.8 mg dose (circle markers). The graph includes sample sizes for each time point and depicts decreasing mean changes with treatment over time.*

FDA Label Image

Figure 3a (Tamsulosin 05)

A line graph depicting mean change in mL/sec over duration of treatment in weeks for Tamsulosin hydrochloride at 0.8 mg and 0.4 mg doses compared to placebo. The graph shows trends for three groups across multiple time points, including baseline (B) and last observation carried forward (LOCF). Sample sizes are noted for each time point.*

FDA Label Image

Figure 3b (Tamsulosin 06)

Line graph showing mean change in mL/sec over time (weeks) for Tamsulosin hydrochloride 0.8 mg, 0.4 mg, and placebo groups. The x-axis represents duration of treatment in weeks, and the y-axis shows mean change in mL/sec. Data points for each dosage and placebo are plotted and connected with lines.*

FDA Label Image

Principal Display Panel (0.4 mg Capsule Bottle Label)

Label for Tamsulosin 0.4 mg, showing manufacturing and packaging details. The label includes batch number 4224612, material number 109471, and quantities in kilograms and units. The product is associated with Synthon Hispania S.L. and lists storage conditions of 15-30°C, with a packaging date of 02.02.2010. The label is in German and relates to Tamsulosin hydrochloride capsules.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.